Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Deerfield Urethane Joins Forces With Olivia Newton-John To Encourage Early Detection Of Breast Cancer
http://www.medicalnewstoday.com/articles/125116.php
Deerfield Urethane, Inc. (Deerfield), a wholly owned subsidiary of Bayer MaterialScience LLC (BMS) and one of the leading suppliers of custom, made-to-order thermoplastic polyurethane (TPU) and specialty elastomer film and sheet, is proud to announce its collaboration with BHS International (BHS), a breast health company co-founded by Olivia Newton-John, in the development and production of the Liv® Aid breast self-exam aid.
New Findings May Improve Treatment Of Inherited Breast Cancer
http://www.medicalnewstoday.com/articles/125076.php
Scientists have identified some of the elusive downstream molecules that play a critical role in the development and progression of familial breast cancer. The research, published by Cell Press in the October 10th issue of the journal <i>Molecular Cell</i>, also identifies a compound found in grapes and red wine as an excellent candidate for treatment of some forms of breast cancer.
Breast Cancer Awareness Month Story Ideas
http://www.medicalnewstoday.com/articles/124988.php
This year, an estimated 182,460 women will hear their doctors say, "You have breast cancer." More than 40,000 women will die from the disease.As October marks Breast Cancer Awareness Month, here are some of the hot topics in breast cancer research and patient care from the University of Michigan Comprehensive Cancer Center:<b>When treatment goes too far</b> Recent research has shown that more women are choosing to have their healthy breast removed after being diagnosed with breast cancer.
----------------------------------------------
** CANCER / ONCOLOGY News **
Deerfield Urethane Joins Forces With Olivia Newton-John To Encourage Early Detection Of Breast Cancer
http://www.medicalnewstoday.com/articles/125116.php
Deerfield Urethane, Inc. (Deerfield), a wholly owned subsidiary of Bayer MaterialScience LLC (BMS) and one of the leading suppliers of custom, made-to-order thermoplastic polyurethane (TPU) and specialty elastomer film and sheet, is proud to announce its collaboration with BHS International (BHS), a breast health company co-founded by Olivia Newton-John, in the development and production of the Liv® Aid breast self-exam aid.
Australian Launch Of Medical Data 'Internet'
http://www.medicalnewstoday.com/articles/125111.php
Medical and life scientists will be able to share information collected from many thousands of cases thanks to a digital network aunched at The Australian National University in CanberraThe ANU node of BioGrid was launched at the John Curtin School of Medical Research, Garran Road, ANU by Senator Kate Lundy.
JCI Online Early Table Of Contents: Oct. 9, 2008
http://www.medicalnewstoday.com/articles/125106.php
<b>VASCULAR BIOLOGY: A real-time view of blood flow through the pancreas</b>A team of researchers at Vanderbilt University, Nashville, has developed a new microscopy approach that enabled them to image, in real time, the flow of blood in mouse pancreatic islets of Langerhans.
Yale Researchers Describe Crossroads In Pathway To Cancer, Diabetes, Heart Disease
http://www.medicalnewstoday.com/articles/125057.php
Yale University researchers have described a molecular traffic signal in the middle of a busy biological highway that influences such diverse processes as the production of insulin, activation of the immune system, creation of new brain cells and formation of tumors.
Roswell Park Hosts Prestigious National Conference The Future Of Cancer Research: Science And Patient Impact
http://www.medicalnewstoday.com/articles/125038.php
Roswell Park Cancer Institute (RPCI) will bring together national cancer experts from around the United States to discuss "The Future of Cancer Research: Science and Patient Impact" during a Centennial Symposium sponsored by the <a href="http://www.
Paul Sullivan's Legacy: An Early Warning Program For Detecting Melanoma Before It's Too Late
http://www.medicalnewstoday.com/articles/124979.php
The Melanoma Foundation of New England and the Boston University School of Medicine are co-sponsoring an Accreditation Council for Continuing Medical Education (ACCME) course to update non-dermatologists on the detection and management of melanoma.
Paper In Cell Cycle Reports Alfacell's ONCONASE(R) Targets SiRNA
http://www.medicalnewstoday.com/articles/124975.php
Alfacell Corporation (Nasdaq: ACEL) announced that a paper published in Cell Cycle (2008; Vol. 7, Issue 20) reports that ONCONASE (ranpirnase) targets small interfering RNA (siRNA), likely within the RNA-induced silencing complex (RISC) of the RNA interference (RNAi) mechanism.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
HPV Vaccine Has Reached Quarter Of Teenage Girls In US
http://www.medicalnewstoday.com/articles/125013.php
A recent survey by US health authorities suggests that about a quarter of American teenage girls have been vaccinated against HPV, the human papillomavirus, which is estimated to cause most cervical cancers.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Watson Receives US FDA Approval For RAPAFLO(TM) (silodosin) For The Treatment Of Benign Prostatic Hyperplasia (BPH)
http://www.medicalnewstoday.com/articles/124978.php
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved RAPAFLO(TM) (silodosin), the company's new alpha blocker for the treatment of the signs and symptoms of BPH.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment